20 Results for "

18:1 PI

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "18:1 PI" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-117163
CAS No.: 2204290-85-5
Purity:  98.93%
Target:  

Wnt β-catenin

Research Areas:  

Cancer

FzM1.8, derives from FzM1, is an allosteric agonist of FZD4 with pEC50 of 6.4. FzM1.8 binds to FZD4 and activates the WNT/β-catenin pathway, by promoting TCF/LEF transcriptional activity in the absence of any WNT ligand. FzM1.8 stabilizes FZD4 with an increased affinity for heterotrimeric G protein and stimulates the release of the Gβγ subunit that in turn activates PI3K .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-NP181
Testosterone/BSA, a conjugate of Testosterone (HY-113415) and bovine serum albumin (BSA), acts as a nuclear transporter and cytoplasmic accumulator. Testosterone/BSA can enter the nuclei of rat testicular spermatocytes, spermatids and rat liver endothelial cells, while the antigenicity of BSA remains intact. Testosterone/BSA accumulates in the cytoplasm of rat hepatocytes in granular form. Testosterone/BSA can be used to investigate the membrane-initiated or non-genomic activities of steroid hormones .
loading...
    loading...
Cat. No.: HY-100355
CAS No.: 2304-81-6
Purity:  99.95%
Synonyms: C18-Ceramide
C18-Ceramide (d18:1/18:0) is a bioactive molecule with multiple functions in cells, not a traditional agonist or inhibitor targeting a single site. It can act on multiple cellular targets, such as proteins related to endoplasmic reticulum stress (e.g., ATF-4, XBP-1, CHOP), proteins in the PI3K/AKT signaling pathway, and SNARE complex proteins. It exerts activities like inducing cell death, promoting autophagy, and regulating exocytosis through mechanisms such as activating endoplasmic reticulum stress, inhibiting the PI3K/AKT signaling pathway, and affecting lipid raft - related functions. It can be used in research on the mechanism of neuronal injury in the field of neuroscience and in the treatment research of cancers such as glioma in the field of oncology .
loading...
    loading...
Cat. No.: HY-157704
CAS No.: 1246303-09-2
18:1 PI(3)P is a kind of biochemical reagent.
loading...
    loading...
Cat. No.: HY-157706
CAS No.: 799268-54-5
Target:  

PI3K

PI(3,4)P2 (18:1) ammonium salt is a phosphatidylinositol 3 kinase (PI3K) activator. PI(3,4)P2 (18:1) ammonium salt is a polyphosphorylated phosphatidylinositol that promotes the activation of AKT (protein kinase B) by activating PI3K, which affects cell metabolism, growth and survival. PI(3,4)P2 (18:1) ammonium salt is also involved in regulating dynamic changes in the cytoskeleton, affecting cell morphology and movement. PI(3,4)P2 (18:1) ammonium salt can be used in research on the development of cancer, diabetes and cardiovascular disease .
loading...
    loading...
Cat. No.: HY-157703
CAS No.: 799268-56-7
Purity:  99.00%
Synonyms: 1,2-Dioleoyl-sn-glycero-3-phospho-1′-myo-inositol-4′,5′-bisphosphate ammonium
18:1 PI(4,5)P2 (1,2-Dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium)) is a kind of biochemical reagent.
loading...
    loading...
18:1 PI(4)P
0 Images
D-myo-Inositol, 1-[(2R)-2,3-bis[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]propyl hydrogen phosphate] 4-(dihydrogen phosphate)
Cat. No.: HY-157701
CAS No.: 1803104-55-3
18:1 PI(4)P is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.
loading...
    loading...
Cat. No.: HY-178923
Research Areas:  

Infection

NNRT-IN-14 is an HIV-1 reverse transcriptase inhibitor (IC50 = 0.175 µM). NNRT-IN-14 can form hydrogen bonds with LYS101, PRO225, and PHE227, and ππ stacking with TYR181 and TRP229. NNRT-IN-14 can be used for the study of HIV .
loading...
    loading...
18:1 Lyso PI ammonium
0 Images
D-myo-Inositol, 1-[(2R)-2-hydroxy-3-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]propyl hydrogen phosphate], ammonium salt (1:1)
Cat. No.: HY-W725832
CAS No.: 1246298-13-4
Synonyms: PI(18:1(9Z)/0:0) ammonium
18:1 Lyso PI (ammonium) is a lysophosphatidylinositol.
loading...
    loading...
Cat. No.: HY-157707
CAS No.: 799268-57-8
18:1 PI(3,4,5)P3 is a biochemical reagent .
loading...
    loading...
18:1 PI ammonium
0 Images
D-myo-Inositol, 1-[(2R)-2,3-bis[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]propyl hydrogen phosphate], ammonium salt (1:1)
Cat. No.: HY-157709
CAS No.: 799268-53-4
Synonyms: DOPI(18:1(9Z)/18:1(9Z)) ammonium
18:1 PI (ammonium) is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.
loading...
    loading...
Cat. No.: HY-146824S
CAS No.: 2342575-35-1
17:0-18:1 PI-d5 (ammonium) is deuterium labeled 17:0-18:1 PI (ammonium).
loading...
    loading...
Cat. No.: HY-N15977
CAS No.: 2260670-01-5
Category:  

Lipids

18:1-6:0 Biotin PI(3,5)P2 ammonium is a biotinylated lipid.
loading...
    loading...
18:1 PI(3,5)P2 triammonium
0 Images
D-myo-Inositol, 1-[(2R)-2,3-bis[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]propyl hydrogen phosphate] 3,5-bis(dihydrogen phosphate), ammonium salt (1:3)
Cat. No.: HY-157705
CAS No.: 799268-55-6
Synonyms: PIP2[3',5'](18:1(9Z)/18:1(9Z)) triammonium
18:1 PI(3,5)P2 (triammonium) is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.
loading...
    loading...
Cat. No.: HY-10109A
Target:  

PI3K Akt

Research Areas:  

Inflammation/Immunology

AS-605240 (potassium) is an orally active PI3Kγ inhibitor (IC50: 8 nM; Ki: 7.8 nM). AS-605240 (potassium) inhibits MCP-1- and CSF1-induced PKB phosphorylation (IC50 values are 0.181 and 0.550 µM, respectively). AS-605240 (potassium) reduces neutrophil recruitment in RANTES (CCL5)- and thioglycolate-induced peritonitis mouse models (EC50 values are 9.1 and 10 mg/kg, respectively). AS-605240 (potassium) ameliorates αCII-IA-induced arthritis in mice .
loading...
    loading...
Cat. No.: HY-W725804
CAS No.: 2410279-92-2
Target:  

Others

Research Areas:  

Metabolic Disease

15:0-18:1 PI (ammonium) is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.
loading...
    loading...
16:0-18:1 PI(4)P ammonium
0 Images
D-myo-Inositol, 4-(dihydrogen phosphate) 1-[(2R)-3-[(1-oxohexadecyl)oxy]-2-[[(9Z)-1-oxo-9-octadecen-1-yl]oxy]propyl hydrogen phosphate], ammonium salt (1:2)
Cat. No.: HY-157621
CAS No.: 2260795-75-1
16:0-18:1 PI(4)P (ammonium) is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.
loading...
    loading...
Cat. No.: HY-N16001
CAS No.: 2260670-03-7
Category:  

Lipids

18:1-6:0 Biotin PI(4,5)P2 triammonium is a biotinylated lipid.
loading...
    loading...
Cat. No.: HY-157619
CAS No.: 50730-13-7
Synonyms: 1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoinositol ammonium
Target:  

Others

Research Areas:  

Metabolic Disease

16:0-18:1 PI (ammonium) is a phosphoinositide. Phosphoinositides (PI) are similar to other phospholipids, but the head group is the cyclic myo-inositol.
loading...
    loading...
Cat. No.: HY-L181
29,828 compounds

Bioactive small molecules are important sources of lead compounds and effective tools for drug screening. Because the target of active small molecules is clear, it is conducive to the study of mechanism. In addition, due to the large structural differences between the individual active molecules, it is easier to obtain a greater variety of lead compounds.

MCE integrates the Bioactive Compound Library (HY-L001) and Novel Bioactive Compound Library (HY-L111) to form the Bioactive Compound Library Max. Bioactive Compound Library Max contains novel active small molecules, molecules that have entered the clinical stage and the market, and small molecules that have been verified by cell experiments or biochemical experiments, which fundamentally expands the number of compound libraries in the library and improves the structural diversity, and is an effective tool to start drug screening and mechanism research.

MCE can provide a library of 29,828 mitophagy compounds, which can be used for drug development and mechanism research in cancer, immunity, infection and other hot research fields.

  • 1